The first quarter of 2026 has witnessed remarkable achievements in China’s innovative drug industry. The total value of out-licensing deals exceeded US$60 billion, nearly half of the total for the ...
A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He didn’t use a patch. He ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results